Total Payments
$448,360
2024 Payments
$47,452
Companies
28
Transactions
467
Medicare Patients
1,611
Medicare Billing
$161,727
Payment Breakdown by Category
Other$198,260 (44.2%)
Consulting$186,120 (41.5%)
Travel$42,598 (9.5%)
Food & Beverage$14,869 (3.3%)
Education$6,512 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $186,120 | 55 | 41.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,200 | 30 | 26.1% |
| Honoraria | $81,061 | 31 | 18.1% |
| Travel and Lodging | $42,598 | 126 | 9.5% |
| Food and Beverage | $14,869 | 222 | 3.3% |
| Education | $6,512 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $66,471 | 68 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $62,480 | 61 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $56,815 | 27 | $0 (2022) |
| MDD US Operations, LLC | $49,243 | 45 | $0 (2024) |
| US WorldMeds, LLC | $44,855 | 83 | $0 (2020) |
| Acorda Therapeutics, Inc | $34,605 | 17 | $0 (2024) |
| Lundbeck LLC | $25,752 | 38 | $0 (2019) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $22,850 | 28 | $0 (2024) |
| ABBVIE INC. | $17,286 | 29 | $0 (2024) |
| Merz North America, Inc. | $15,859 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,452 | 62 | Amneal Pharmaceuticals LLC ($18,849) |
| 2023 | $41,149 | 55 | MDD US Operations, LLC ($30,823) |
| 2022 | $7,515 | 8 | Sunovion Pharmaceuticals Inc. ($4,082) |
| 2021 | $50,814 | 37 | Amneal Pharmaceuticals LLC ($19,861) |
| 2020 | $20,001 | 10 | ACADIA Pharmaceuticals Inc ($5,139) |
| 2019 | $101,040 | 113 | Amneal Pharmaceuticals LLC ($23,340) |
| 2018 | $101,450 | 102 | Sunovion Pharmaceuticals Inc. ($19,125) |
| 2017 | $78,940 | 80 | ACADIA Pharmaceuticals Inc ($35,331) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $126.38 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Honoraria | Cash or cash equivalent | $3,375.00 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| 10/16/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Travel and Lodging | In-kind items and services | $123.38 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | VYALEV (Drug) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Education | In-kind items and services | $6,075.00 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | VYALEV (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Travel and Lodging | In-kind items and services | $370.95 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Education | In-kind items and services | $337.50 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Travel and Lodging | In-kind items and services | $336.28 | General |
| Category: NEUROLOGY | ||||||
| 09/29/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $135.77 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: NEUROLOGY | ||||||
| 09/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROLOGY | ||||||
| 09/20/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 09/20/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEUROLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $167.02 | General |
| 07/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $51.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 384 | 524 | $175,105 | $39,584 |
| 2022 | 4 | 406 | 546 | $144,975 | $40,843 |
| 2021 | 5 | 411 | 601 | $145,828 | $47,905 |
| 2020 | 6 | 410 | 533 | $127,905 | $33,396 |
Total Patients
1,611
Total Services
2,204
Medicare Billing
$161,727
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 280 | 359 | $108,777 | $22,513 | 20.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 48 | 48 | $21,216 | $6,044 | 28.5% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Facility | 2023 | 14 | 51 | $18,252 | $4,359 | 23.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 16 | 40 | $17,760 | $3,975 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 26 | 26 | $9,100 | $2,693 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 307 | 415 | $94,291 | $25,886 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 58 | 58 | $24,836 | $7,553 | 30.4% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Facility | 2022 | 13 | 43 | $16,412 | $3,963 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 30 | $9,436 | $3,440 | 36.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 286 | 438 | $84,534 | $29,193 | 34.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 61 | 61 | $25,437 | $7,991 | 31.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 39 | 40 | $10,960 | $4,500 | 41.1% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 13 | 30 | $13,825 | $3,423 | 24.8% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Facility | 2021 | 12 | 32 | $11,072 | $2,797 | 25.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 238 | 339 | $65,427 | $17,204 | 26.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 47 | 47 | $19,599 | $5,291 | 27.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 46 | 49 | $13,426 | $3,759 | 28.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 52 | 52 | $13,780 | $3,108 | 22.6% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Facility | 2020 | 11 | 30 | $10,553 | $2,483 | 23.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 16 | 16 | $5,120 | $1,551 | 30.3% |
About Dr. Alberto Espay, MD
Dr. Alberto Espay, MD is a Neurology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023057940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alberto Espay, MD has received a total of $448,360 in payments from pharmaceutical and medical device companies, with $47,452 received in 2024. These payments were reported across 467 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($186,120).
As a Medicare-enrolled provider, Espay has provided services to 1,611 Medicare beneficiaries, totaling 2,204 services with total Medicare billing of $161,727. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cincinnati, OH
- Active Since 06/06/2006
- Last Updated 05/01/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023057940
Products in Payments
- APOKYN (Drug) $68,582
- NUPLAZID (Drug) $66,471
- RYTARY (Drug) $33,680
- NORTHERA (Drug) $25,752
- CREXONT (Drug) $16,226
- XEOMIN (Biological) $15,859
- Dhivy (Drug) $12,938
- APL-130277 (Drug) $11,261
- Duopa (Drug) $8,116
- Xadago (Drug) $7,560
- MYOBLOC (Biological) $6,714
- VYALEV (Drug) $5,600
- ACTIVA (Device) $4,029
- Apokyn (Drug) $3,740
- INBRIJA (Drug) $3,725
- APTIOM (Drug) $3,311
- NOURIANZ (Drug) $2,822
- OSMOLEX ER (Drug) $2,789
- Nourianz (Drug) $1,250
- INFINITY (Device) $575.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cincinnati
Aram Zabeti, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Brian Moseley, Md, MD
Neurology — Payments: $700,525
Neurology $700,525
Dr. Hope O'brien, Md, MD
Neurology — Payments: $530,605
Neurology $530,605
Mrs. Susan Hibbs, Md, MD
Neurology — Payments: $255,533
Neurology $255,533
Zainab Contractor, Md, MD
Neurology — Payments: $212,716
Neurology $212,716
Reena Shah, Md, MD
Neurology — Payments: $173,678
Neurology $173,678